Simulations Plus

Simulations Plus is a developer of drug discovery and development software for mechanistic modeling and simulation, and for machine-learning-based prediction of properties of molecules solely from their structure. The company also provides consulting services. The company provides various software products for pharmaceutical research and development, including: simulation programs that provide time-dependent results based on solving sets of differential equations: GastroPlus?; DDDPlus?; MembranePlus?; DILIsym?; and NAFLDsym?; programs that are based on predicting and analyzing static properties of chemicals: ADMET Predictor?; MedChem Designer?; and MedChem Studio?; PKPlus?; and KIWI?.
  • TickerSLP
  • ISINUS8292141053
  • ExchangeNASDAQ Stock Market
  • SectorSoftware & Computer Services
  • CountryUnited States
 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Celebrates 25 Years in Business

LANCASTER, Calif.--(BUSINESS WIRE)-- This month marks the 25th anniversary of Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries. In celebration of its achievements, Simulations Plus will host a series of exciting events throughout the year to share the milestones and challenges of the last 25 years while looking ahead to future opportunities. “We are very proud and humbled by our achievements at SLP over these past 25 years and look forward to celebrating this milestone o...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the third quarter of fiscal year 2021, the period ended May 31, 2021, after the close of the financial markets on Monday, July 12, 2021. The Company will host a conference call on July 12, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be avail...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantita...

LANCASTER, Calif.--(BUSINESS WIRE)-- (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has released version 1A, quantitative systems pharmacology modeling software to support the development of treatments for idiopathic pulmonary fibrosis. IPF is the most common type of pulmonary fibrosis, a disease that causes scarring (fibrosis) of the lungs. The development effort leading up to this release was sponsored by a leading pharmaceutical company that is also utilizing the software for evaluation of ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutio...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 18th Annual Institutional Investor Conference on Wednesday, June 2, 2021. Each year, Craig-Hallum hosts a multi-industry investor conference in Minneapolis featuring over 150 public companies where institutional clients can meet formally with corporate management. This year’s conference will be virtual ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Present at 16th Annual Needham Virtual Technology ...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will present at the 16th Annual Needham Virtual Technology and Media Conference on Thursday, May 20, 2021, at 1:30 p.m. ET. In addition to his presentation, Mr. O’Connor will be joined by chief financial officer Will Frederick to host one-on-one meetings throughout the day. This year’s conference will provide shareholders and investors t...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Celebrates 25 Years in Business

LANCASTER, Calif.--(BUSINESS WIRE)-- This month marks the 25th anniversary of Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries. In celebration of its achievements, Simulations Plus will host a series of exciting events throughout the year to share the milestones and challenges of the last 25 years while looking ahead to future opportunities. “We are very proud and humbled by our achievements at SLP over these past 25 years and look forward to celebrating this milestone o...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the third quarter of fiscal year 2021, the period ended May 31, 2021, after the close of the financial markets on Monday, July 12, 2021. The Company will host a conference call on July 12, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be avail...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantita...

LANCASTER, Calif.--(BUSINESS WIRE)-- (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has released version 1A, quantitative systems pharmacology modeling software to support the development of treatments for idiopathic pulmonary fibrosis. IPF is the most common type of pulmonary fibrosis, a disease that causes scarring (fibrosis) of the lungs. The development effort leading up to this release was sponsored by a leading pharmaceutical company that is also utilizing the software for evaluation of ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutio...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 18th Annual Institutional Investor Conference on Wednesday, June 2, 2021. Each year, Craig-Hallum hosts a multi-industry investor conference in Minneapolis featuring over 150 public companies where institutional clients can meet formally with corporate management. This year’s conference will be virtual ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Present at 16th Annual Needham Virtual Technology ...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will present at the 16th Annual Needham Virtual Technology and Media Conference on Thursday, May 20, 2021, at 1:30 p.m. ET. In addition to his presentation, Mr. O’Connor will be joined by chief financial officer Will Frederick to host one-on-one meetings throughout the day. This year’s conference will provide shareholders and investors t...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Celebrates 25 Years in Business

LANCASTER, Calif.--(BUSINESS WIRE)-- This month marks the 25th anniversary of Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries. In celebration of its achievements, Simulations Plus will host a series of exciting events throughout the year to share the milestones and challenges of the last 25 years while looking ahead to future opportunities. “We are very proud and humbled by our achievements at SLP over these past 25 years and look forward to celebrating this milestone o...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the third quarter of fiscal year 2021, the period ended May 31, 2021, after the close of the financial markets on Monday, July 12, 2021. The Company will host a conference call on July 12, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be avail...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantita...

LANCASTER, Calif.--(BUSINESS WIRE)-- (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has released version 1A, quantitative systems pharmacology modeling software to support the development of treatments for idiopathic pulmonary fibrosis. IPF is the most common type of pulmonary fibrosis, a disease that causes scarring (fibrosis) of the lungs. The development effort leading up to this release was sponsored by a leading pharmaceutical company that is also utilizing the software for evaluation of ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutio...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 18th Annual Institutional Investor Conference on Wednesday, June 2, 2021. Each year, Craig-Hallum hosts a multi-industry investor conference in Minneapolis featuring over 150 public companies where institutional clients can meet formally with corporate management. This year’s conference will be virtual ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Present at 16th Annual Needham Virtual Technology ...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will present at the 16th Annual Needham Virtual Technology and Media Conference on Thursday, May 20, 2021, at 1:30 p.m. ET. In addition to his presentation, Mr. O’Connor will be joined by chief financial officer Will Frederick to host one-on-one meetings throughout the day. This year’s conference will provide shareholders and investors t...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Celebrates 25 Years in Business

LANCASTER, Calif.--(BUSINESS WIRE)-- This month marks the 25th anniversary of Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries. In celebration of its achievements, Simulations Plus will host a series of exciting events throughout the year to share the milestones and challenges of the last 25 years while looking ahead to future opportunities. “We are very proud and humbled by our achievements at SLP over these past 25 years and look forward to celebrating this milestone o...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the third quarter of fiscal year 2021, the period ended May 31, 2021, after the close of the financial markets on Monday, July 12, 2021. The Company will host a conference call on July 12, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be avail...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantita...

LANCASTER, Calif.--(BUSINESS WIRE)-- (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has released version 1A, quantitative systems pharmacology modeling software to support the development of treatments for idiopathic pulmonary fibrosis. IPF is the most common type of pulmonary fibrosis, a disease that causes scarring (fibrosis) of the lungs. The development effort leading up to this release was sponsored by a leading pharmaceutical company that is also utilizing the software for evaluation of ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutio...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 18th Annual Institutional Investor Conference on Wednesday, June 2, 2021. Each year, Craig-Hallum hosts a multi-industry investor conference in Minneapolis featuring over 150 public companies where institutional clients can meet formally with corporate management. This year’s conference will be virtual ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Present at 16th Annual Needham Virtual Technology ...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will present at the 16th Annual Needham Virtual Technology and Media Conference on Thursday, May 20, 2021, at 1:30 p.m. ET. In addition to his presentation, Mr. O’Connor will be joined by chief financial officer Will Frederick to host one-on-one meetings throughout the day. This year’s conference will provide shareholders and investors t...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Celebrates 25 Years in Business

LANCASTER, Calif.--(BUSINESS WIRE)-- This month marks the 25th anniversary of Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries. In celebration of its achievements, Simulations Plus will host a series of exciting events throughout the year to share the milestones and challenges of the last 25 years while looking ahead to future opportunities. “We are very proud and humbled by our achievements at SLP over these past 25 years and look forward to celebrating this milestone o...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the third quarter of fiscal year 2021, the period ended May 31, 2021, after the close of the financial markets on Monday, July 12, 2021. The Company will host a conference call on July 12, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be avail...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantita...

LANCASTER, Calif.--(BUSINESS WIRE)-- (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has released version 1A, quantitative systems pharmacology modeling software to support the development of treatments for idiopathic pulmonary fibrosis. IPF is the most common type of pulmonary fibrosis, a disease that causes scarring (fibrosis) of the lungs. The development effort leading up to this release was sponsored by a leading pharmaceutical company that is also utilizing the software for evaluation of ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutio...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 18th Annual Institutional Investor Conference on Wednesday, June 2, 2021. Each year, Craig-Hallum hosts a multi-industry investor conference in Minneapolis featuring over 150 public companies where institutional clients can meet formally with corporate management. This year’s conference will be virtual ...

 PRESS RELEASE
SLP Simulations Plu... (Technology)

Simulations Plus to Present at 16th Annual Needham Virtual Technology ...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will present at the 16th Annual Needham Virtual Technology and Media Conference on Thursday, May 20, 2021, at 1:30 p.m. ET. In addition to his presentation, Mr. O’Connor will be joined by chief financial officer Will Frederick to host one-on-one meetings throughout the day. This year’s conference will provide shareholders and investors t...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch